BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  CareDx Reports Third Quarter 2017 Financial Results

  Achieved total revenue for the third quarter of 2017 of $12.2 million.

  November 10, 2017

   · 

  13 min read
• Biotech Beach

  BioDiscovery Launches Nxclinical 4.0, a Unique System Allowing Analysis and Interpretation of CNV, SNV, and AOH From A Single NGS Assay

  BioDiscovery launched, at the 2017 American Society of Human Genetics Meeting, a unique software solution for interrogation of copy number, sequence variants, and allelic changes obtained from a single NGS assay.

  November 10, 2017

   · 

  5 min read
• Business

  ARCA biopharma Announces Third Quarter 2017 Financial Results and Provides Business Update

  Cash, cash equivalents and marketable securities totaled $16.0 million as of September 30, 2017, compared to $23.5 million as of December 31, 2016.

  November 10, 2017

   · 

  7 min read
• Business

  Dova Pharmaceuticals Reports Third Quarter 2017 Operating and Financial Results

  Dova reported a net loss of $9.7 million for the third quarter of 2017, compared to a net loss of $7.2 million for the same period in 2016.

  November 10, 2017

   · 

  6 min read
• Business

  KemPharm Reports Third Quarter 2017 Results and Provides Corporate Update

  Net loss of $0.68 per basic and diluted share for the quarter ended September 30, 2017.

  November 10, 2017

   · 

  13 min read
• Drug Development

  Sage Therapeutics Announces Brexanolone Achieves Primary Endpoints in Both Phase II Clinical Trials in Postpartum Depression

  Brexanolone achieved the primary endpoint in both trials, a mean reduction from baseline in the Hamilton Rating Scale for Depression total score compared to placebo at 60 hours.

  November 10, 2017

   · 

  13 min read
• Business

  Neovasc Inc. to Host Third Quarter 2017 Conference Call

  The Company will subsequently hold a conference call that same day at 4:30 pm Eastern Time hosted by Mr. Alexei Marko, CEO, and Mr. Chris Clark, CFO.

  November 10, 2017

   · 

  1 min read
• Policy

  Vanda Receives Negative Opinion for Marketing Authorization From the European Medicines Agency on Fanaptum for the Treatment of Schizophrenia

  After considering the grounds for this request, the CHMP re-examined the opinion and confirmed the refusal of the Fanaptum MAA on November 9, 2017.

  November 10, 2017

   · 

  1 min read
• Pharm Country

  BOC Sciences Newly Broadens its Custom Synthesis Service Range

  On October 16, 2017, BOC Sciences pronounced to broaden its custom synthesis service range which already exists.

  November 10, 2017

   · 

  1 min read
• Pharm Country

  Mylan Announces Voluntary Delisting From the Tel Aviv Stock Exchange (TASE)

  Under Israeli law, the delisting of Mylan’s ordinary shares from the TASE will become effective in three months, on Feb. 12, 2018.

  November 10, 2017

   · 

  2 min read